Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vera Therapeutics, Inc. (VERA)
:VERA
Holding VERA?
Track your performance easily
Vera Therapeutics (VERA) Ownership Overview
13.61% Insiders
15.97% Mutual Funds
0.10% Other Institutional Investors
13.68% ETFs
56.63% Public Companies and Individual Investors
The ownership structure of Vera Therapeutics (VERA) stock is a mix of institutional, retail, and individual investors. Approximately 29.75% of the company’s stock is owned by Institutional Investors, 13.61% is owned by Insiders, and 56.63% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 17, 2024 | Joseph R Young Svp, Finance, Chief Acct Offcr | xxxxxxxxxxxxx | $1304249 |
| Apr 05, 2024 | Sean Grant Cfo | xxxxxxxxxxxxx | $4689466 |
| Mar 25, 2024 | Maha Katabi Director | xxxxxxxxxxxxx | $34099583 |
| Feb 01, 2024 | Maha Katabi Director | xxxxxxxxxxxxx | $4999990 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $618 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $4721223 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $6072593 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $44239470 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,144,212 | Insider | 8.12% | 174,285,903 | |
| 2,793,987 | Insider | 4.41% | 94,660,280 | |
| 2,650,886 | Institution | 4.19% | 89,812,018 | |
| 2,159,300 | Institution | 3.41% | 73,157,084 | |
| 2,158,673 | Institution | 3.41% | 73,135,841 | |
| 2,026,192 | Institution | 3.20% | 68,647,385 | |
| 1,474,854 | Institution | 2.33% | 49,968,054 | |
| 1,335,088 | Institution | 2.11% | 45,232,781 | |
| 1,112,132 | Institution | 1.76% | 37,679,032 | |
| 1,062,686 | Institution | 1.68% | 36,003,802 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,026,192 | Institution | 3.20% | 68,647,385 | |
| 1,474,854 | Institution | 2.33% | 49,968,054 | |
| 1,335,088 | Institution | 2.11% | 45,232,781 | |
| 1,112,132 | Institution | 1.76% | 37,679,032 | |
| 484,378 | Institution | 0.76% | 16,410,727 | |
| 478,644 | Institution | 0.76% | 16,216,459 | |
| 425,985 | Institution | 0.67% | 14,432,372 | |
| 396,414 | Institution | 0.63% | 13,430,506 | |
| 338,858 | Institution | 0.54% | 11,480,509 | |
| 309,178 | Institution | 0.49% | 10,474,951 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,461,058 | Institution | 2.31% | 72,687,636 | |
| 1,184,601 | Institution | 1.87% | 40,134,282 | |
| 977,930 | Institution | 1.54% | 33,826,599 | |
| 804,245 | Institution | 1.27% | 40,011,189 | |
| 618,047 | Institution | 0.98% | 21,378,246 | |
| 618,047 | Institution | 0.98% | 21,378,246 | |
| 406,012 | Institution | 0.64% | 13,755,687 | |
| 312,780 | Institution | 0.49% | 10,596,986 | |
| 266,946 | Institution | 0.42% | 9,233,662 | |
| 183,336 | Institution | 0.29% | 9,120,966 |
FAQ
Who Owns Vera Therapeutics, Inc. (VERA)?
According to the latest TipRanks data, approximately 0.10% of the company's stock is held by institutional investors, 13.61% is held by insiders, and 56.63% is held by retail investors.
What percentage of Vera Therapeutics, Inc. (VERA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.10% of Vera Therapeutics, Inc. (VERA) stock is held by institutional investors.
What percentage of Vera Therapeutics, Inc. (VERA) stock is held by retail investors?
According to the latest TipRanks data, approximately 56.63% of Vera Therapeutics, Inc. (VERA) stock is held by retail investors.
Who owns the most shares of Vera Therapeutics, Inc. (VERA)?
Patrick Enright owns the most shares of Vera Therapeutics, Inc. (VERA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.